BWBo Wu

Bo Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Bo Wu has a total of 81 co-authors. Here are the top co-authors by number of shared publications:

  • Jie Kang

    6 shared publications
  • Fan Yu

    Department of Nuclear Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

    5 shared publications
  • Xiaoping Zhang

    Clinical Nuclear Medicine Center, Imaging Clinical Medical Center, Institute of Nuclear Medicine, Department of Nuclear Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, China.; Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai People's Hospital, Zhuhai Hospital Affiliated with Jinan University, Jinan University, Zhuhai, 519000, China.

    5 shared publications
  • Chengyou Jia

    Department of Nuclear Medicine, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, China

    4 shared publications
  • Haidong Cai

    Department of Nuclear Medicine, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, China

    4 shared publications
  • Xianzhao Deng

    Department of General Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, 600 Yishan Road, Shanghai, 200233, China

    4 shared publications

Latest Publications

  • Open Access

    Development and validation of prediction models for biochemical hypocalcemia after parathyroidectomy in primary hyperparathyroidism

    by Qixian Lin, Ling Zhan, Lingzi Pan, Jie Kang, Zihan Lin, Bo Wu

    Background: Postoperative biochemical hypocalcemia is a common complication after parathyroidectomy for primary hyperparathyroidism (PHPT). This study aimed to develop and internally validate preoperative prediction models and to determine whether machine-learning methods improve prediction over conventional logistic regression (LR). Methods: This single-center retrospective study included 453 patients with PHPT who underwent parathyroidectomy between January 2017 and December 2025. Nine preoperative predictors were prespecified. Eight primary models, including LR and seven machine-learning algorithms, were evaluated using repeated nested stratified cross-validation. A spline-augmented LR model was examined in sensitivity analysis. Performance was assessed using area under the curve (AUC), Brier score, calibration, and decision-curve analysis. Results: Postoperative biochemical hypocalcemia occurred in 89 patients (19.7%). LR showed the most favorable overall performance, with a mean AUC of 0.814 [standard deviation (SD), 0.004] and Brier score of 0.115 (SD, 0.001). Extreme gradient boosting (XGBoost) achieved the highest AUC among machine-learning models (0.796; SD, 0.009). Based on averaged repeated out-of-fold predictions, AUCs were 0.817 [95% confidence interval (CI): 0.767–0.863] for LR and 0.808 (95% CI: 0.754–0.856) for XGBoost, with no evidence of superior discrimination by XGBoost. The spline sensitivity analysis did not improve performance. LR showed acceptable calibration, and both LR and XGBoost demonstrated positive net benefit across the evaluated threshold range. Conclusions: More complex machine-learning algorithms did not demonstrate a clear predictive advantage over conventional LR. LR provided stable discrimination, low overall prediction error and acceptable calibration and was retained as the primary model. External validation and prospective assessment of clinical impact are required before routine clinical implementation.

  • Open Access

    Age-stratified differences in asymptomatic primary hyperparathyroidism: a single-center cohort study from 2017 to 2024

    by Zihan Lin, Fan Yu, Hangzhou Yang, Zixia Tao, Lingzi Pan, Zhiyi Cheng, Xianzhao Deng, Bo Wu

    Background: Primary hyperparathyroidism (PHPT) is increasingly diagnosed as asymptomatic due to routine biochemical screening. While parathyroidectomy (PTX) is the definitive treatment, age-specific management strategies for asymptomatic patients remain contentious, particularly in patients >50 years. Current evidence lacks detailed comparisons of disease characteristics and surgical outcomes across age-stratified asymptomatic cohorts. This study aims to bridge this information gap. Methods: This retrospective cohort study analyzed 199 asymptomatic PHPT patients who underwent PTX at Shanghai Sixth People’s Hospital between 2017 and 2024. Data regarding demographics, biochemical parameters, imaging data, surgical details, complications and outcomes were collected and compared by age at diagnosis (≤50 or >50 years). Results: Among 199 patients who underwent PTX, 128 (64.3%) were >50 years old and 71 (35.7%) were ≤50. Patients in the younger cohort (≤50 years) exhibited significantly lower preoperative 25-hydroxyvitamin D levels (Pvs. 71.9%; P=0.03; V=0.15). Transient hypocalcemia occurred more frequently in patients ≤50 years (18.3% vs. 13.3%), although this difference was not statistically significant (P=0.34). No significant intergroup differences were observed in other postoperative complications or cure rates. Conclusions: Patients ≤50 years demonstrated superior preoperative localization accuracy, which was associated with larger tumor size. Patients >50 years exhibited a non-significantly lower trend in transient hypocalcemia. Both age cohorts achieved comparably high surgical cure rates, supporting the efficacy of PTX across age groups for asymptomatic PHPT.

  • Open Access

    A novel automated parathyroid glands detection and segmentation method in thyroidectomy

    by Fan Yu, Xiaolei Yi, Zihan Lin, Hong Chen, Jie Kang, Yinyue Wu, Xuehai Ding, Quanyong Luo, Bo Wu

    Intraoperative preservation of parathyroid glands (PGs) remained a significant challenge in thyroidectomy. Recently, deep learning has demonstrated conside


  • Open Access

    Identifying risk factors for postoperative hypocalcemia in primary hyperparathyroidism: 12-year experience in a tertiary hospital

    by Zihan Lin, Qixian Lin, Hangzhou Yang, Jie Kang, Fan Yu, Lingzi Pan, Bo Wu

    Background: Hypocalcemia is the most common complication following parathyroidectomy (PTX) in patients with primary hyperparathyroidism (PHPT). With asymptomatic PHPT cases increasingly comprising a larger proportion of clinical presentations, the association between preoperative symptom status and postoperative hypocalcemia risk remains poorly defined. This study aimed to identify risk factors for hypocalcemia after PTX in symptomatic vs. asymptomatic PHPT patients to enable individualized calcium management protocols. Methods: A retrospective analysis was performed on patients with primary PHPT who underwent PTX between July 2012 and August 2024. A total of 478 patients were included and categorized into two groups based on symptomatic status at admission. Data regarding demographics, surgical details, and laboratory parameters were collected. Univariate and multivariate analyses were performed to identify factors associated with postoperative hypocalcemia in PHPT patients. Results: Multivariate analysis revealed that the preoperative serum chloride/calcium (Cl/Ca) ratio [odds ratio (OR) =1.104; 95% confidence interval (CI): 1.025–1.190; P=0.009], alkaline phosphatase (OR =1.002; 95% CI: 1.001–1.003; P=0.001) and female gender (OR =0.257; 95% CI: 0.103–0.641; P=0.004) were statistically significant predictors of early postoperative hypocalcemia in the symptomatic group. In the asymptomatic group, age ≤60 years (OR =0.379; 95% CI: 0.161–0.894; P=0.03) and a higher preoperative serum Cl/Ca ratio (OR =1.335; 95% CI: 1.170–1.523; PConclusions: This first stratification analysis of PHPT patients by symptomatic status identified the serum Ca/Cl ratio as a common, independent predictor of post-PTX hypocalcemia in both symptomatic and asymptomatic groups. Additionally, in symptomatic patients, alkaline phosphatase levels and female gender were associated with early hypocalcemia. Conversely, for asymptomatic patients, age ≤60 years emerged as a significant predictor.


  • Open Access

    Fluorescence intensity of parathyroid glands in thyroid and parathyroid surgery: a near-infrared autofluorescence study

    by Fan Yu, Xiaolei Yi, Zihan Lin, Yinyue Wu, Quanyong Luo, Bo Wu, \R\Nfan Yu

    Objective: Near-infrared autofluorescence (NIRAF) imaging shows promise in identifying parathyroid gland (PG) during surgery. However, the clinical application of NIRAF faces challenges due to the heterogeneous fluorescence intensity (FI) of PGs observed in different thyroid and parathyroid diseases. This study aimed to evaluate the effectiveness of NIRAF in PG detection and to analyze the FI of PGs in patients with various thyroid and parathyroid diseases.Methods: A total of 105 patients undergoing thyroidectomy and parathyroidectomy were enrolled. Intraoperative NIRAF imaging was used to detect PGs, and the FI values were quantified using ImageJ software. Normal PGs were grouped according to the pathological results of ipsilateral thyroid diseases. Compare and analyze the FI values of normal and diseased PGs.Results: A total of 239 PGs were detected during surgery. 225 PGs were identified by NIRAF. The NIRAF identification rate was significantly higher than visual identification (94.1% vs. 81.2%, p < 0.001). NIRAF demonstrated high performance in PG identification, with sensitivity, specificity, and positive predictive values and negative predictive values to predict PGs were 95.4%, 77.5%, 90.5% and 88.1%, respectively. The FI of PGs was higher in patients with papillary thyroid carcinoma (1.39 ± 0.21), follicular nodules of thyroid (1.45 ± 0.25), nodular thyroid gland (1.36 ± 0.19) than in those with hyperthyroidism (1.06 ± 0.28) and primary hyperparathyroidism (1.17 ± 0.23). Superior PGs in Stage I exhibited higher FI compared to PGs in Stage II (p = 0.025). In Stage II, the FI of inferior PGs was significantly higher than that of superior PGs (p < 0.001). The FI of PGs in both Stage I and II was significantly higher than in Stage III.Conclusions: NIRAF demonstrates high efficiency in identifying PGs across various surgical stages, outperforming conventional visual identification. The FI of superior and inferior PGs exhibits significant variability across different intraoperative stages. Surgeons should exercise caution when identifying PGs in patients with primary hyperparathyroidism and hyperthyroidism, as these conditions are associated with lower FI compared to other thyroid diseases.


  • Open Access

    Alteration of Thyroid Hormones in Mouse Models of Alzheimer’s Disease and Aging

    by Siyuan Zhu, Yidan Pang, Xiangwei Zhang, Chunying Yang, Junjie Gao, Ping Fang, Yaohui Zhang, Yunjin Yao, Fangyu Ju, Fang Ye, et al.

    Introduction: Aging is characterized by the deterioration of a wide range of functions in tissues and organs, and Alzheimer’s disease (AD) is a neurodegenerative disease characterized by cognitive impairment. Hypothyroidism occurs when there is insufficient production of thyroid hormones (THs) by the thyroid. The relationship between hypothyroidism and aging as well as AD is controversial at present. Methods: We established an animal model of AD (FAD4T) with mutations in the APP and PSEN1 genes, and we performed a thyroid function test and RNA sequencing (RNA-Seq) of the thyroid from FAD4T and naturally aging mice. We also studied gene perturbation correlation in the FAD4T mouse thyroid, bone marrow, and brain by further single-cell RNA sequencing (scRNA-seq) data of the bone marrow and brain. Results: In this study, we found alterations in THs in both AD and aging mice. RNA-seq data showed significant upregulation of T-cell infiltration- and cell proliferation-related genes in FAD4T mouse thyroid. In addition, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses revealed that upregulated genes were enriched in the functional gene modules of activation of immune cells. Downregulated energy metabolism-related genes were prominent in aging thyroids, which reflected the reduction in THs. GSEA showed a similar enrichment tendency in both mouse thyroids, suggesting their analogous inflammation state. In addition, the regulation of leukocyte activation and migration was a common signature between the thyroid, brain, and bone marrow of FAD4T mice. Conclusions: Our findings identified immune cell infiltration of the thyroid as the potential underlying mechanism of the alteration of THs in AD and aging.


  • Open Access

    Fasting regulates mitochondrial function through lncRNA PRKCQ-AS1-mediated IGF2BPs in papillary thyroid carcinoma

    by Xiaoping Zhang, Yong Zhong, Lin Liu, Chengyou Jia, Haidong Cai, Jianshe Yang, Bo Wu, Zhongwei Lv

    Recurring evidence suggests that fasting has extensive antitumor effects in various cancers, including papillary thyroid carcinoma (PTC). However, the underlying mechanism of this relationship with PTC is unknown. In this study, we study the effect of fasting on glycolysis and mitochondrial function in PTC. We find that fasting impairs glycolysis and reduces mitochondrial dysfunction in vitro and in vivo and also fasting in vitro and fasting mimicking diets (FMD) in vivo significantly increase the expression of lncRNA-protein kinase C theta antisense RNA 1 (PRKCQ-AS1), during the inhibition of TPC cell glycolysis and mitochondrial function. Moreover, lncRNA PRKCQ-AS1 was significantly lower in PTC tissues and cells. In addition, PRKCQ-AS1 overexpression increased PTC cell glycolysis and mitochondrial function; PRKCQ-AS1 knockdown has the opposite effect. On further mechanistic analysis, we identified that PRKCQ-AS1 physically interacts with IGF2BPs and enhances protein arginine methyltransferases 7 (PRMT7) mRNA, which is the key player in regulating glycolysis and mitochondrial function in PTC. Hence, PRKCQ-AS1 inhibits tumor growth while regulating glycolysis and mitochondrial functions via IGF2BPs/PRMT7 signaling. These results indicate that lncRNA PRKCQ-AS1 is a key downstream target of fasting and is involved in PTC metabolic reprogramming. Further, the PRKCQ-AS1/IGF2BPs/PRMT7 axis is an ideal therapeutic target for PTC diagnosis and treatment.


  • Open Access

    HOXD9/miR-451a/PSMB8 axis is implicated in the regulation of cell proliferation and metastasis via PI3K/AKT signaling pathway in human anaplastic thyroid carcinoma

    by Yong Zhong, Fan Yu, Ling Yang, Yu Wang, Lin Liu, Chengyou Jia, Haidong Cai, Jianshe Yang, Shiyang Sheng, Zhongwei Lv, et al.

    Anaplastic thyroid carcinoma (ATC) is a deadly disease with a poor prognosis. Thus, there is a pressing need to determine the mechanism of ATC progression. The homeobox D9 (HOXD9) transcription factor has been associated with numerous malignancies but its role in ATC is unclear. In the present study, the carcinogenic potential of HOXD9 in ATC was investigated. We assessed the differential expression of HOXD9 on cell proliferation, migration, invasion, apoptosis, and epithelial–mesenchymal transition (EMT) in ATC and explored the interactions between HOXD9, microRNA-451a (miR-451a), and proteasome 20S subunit beta 8 (PSMB8). In addition, subcutaneous tumorigenesis and lung metastasis in mouse models were established to investigate the role of HOXD9 in ATC progression and metastasis in vivo. HOXD9 expression was enhanced in ATC tissues and cells. Knockdown of HOXD9 inhibited cell proliferation, migration, invasion, and EMT but increased apoptosis in ATC cells. The UCSC Genome Browser and JASPAR database identified HOXD9 as an upstream regulator of miR-451a. The direct binding of miR-451a to the untranslated region (3′-UTR) of PSMB8 was established using a luciferase experiment. Blocking or activation of PI3K by LY294002 or 740Y-P could attenuate the effect of HOXD9 interference or overexpression on ATC progression. The PI3K/AKT signaling pathway was involved in HOXD9-stimulated ATC cell proliferation and EMT. Consistent with in vitro findings, the downregulation of HOXD9 in ATC cells impeded tumor growth and lung metastasis in vivo. Our research suggests that through PI3K/AKT signaling, the HOXD9/miR-451a/PSMB8 axis may have significance in the control of cell proliferation and metastasis in ATC. Thus, HOXD9 could serve as a potential target for the diagnosis of ATC. Graphical Abstract